Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | REN | P00797 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 3/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.34 |
| ▸ | STAT6 | P42226 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3776724 | 0.85 | LDHA (0.54) | MMP13ITGB3ITGA2BLDHAREN | |
| SCHEMBL10785304 | 0.85 | MMP13 (0.43) | MMP13ITGB3ITGA2BLDHAREN | |
| SCHEMBL6942693 | 0.85 | LDHA (0.54) | MMP13ITGB3ITGA2BLDHAREN | |
| SCHEMBL2292028 | 0.83 | MMP13 (0.57) | MMP13ITGB3ITGA2BPPARGPPARA | |
| SCHEMBL18918280 | 0.82 | GRB2 (0.44) | MMP13ITGB3ITGA2BLDHABLM | |
| SCHEMBL15433042 | 0.82 | GRB2 (0.44) | MMP13ITGB3ITGA2BLDHABLM | |
| SCHEMBL25173080 | 0.82 | PPARG (0.40) | MMP13ITGB3ITGA2BLDHAREN | |
| SCHEMBL4778626 | 0.82 | CTSS (0.44) | MMP13ITGB3ITGA2BBLMREN | |
| SCHEMBL6661008 | 0.82 | CTSS (0.44) | MMP13ITGB3ITGA2BBLMREN | |
| SCHEMBL8766144 | 0.82 | CTSS (0.44) | MMP13ITGB3ITGA2BBLMREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170157262-A1 | CONJUGATES OF CELL BINDING MOLECULES WITH CYTOTOXIC AGENTS | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170157262-A1 | CONJUGATES OF CELL BINDING MOLECULES WITH CYTOTOXIC AGENTS | CD4, CD2, CD47 | MMP13 2424/4885ITGB3 269/4885ITGA2B 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.